Search results for "progre"

showing 10 items of 1746 documents

Physical Activity, Incidence, and Progression of Age-Related Macular Degeneration: A Multicohort Study.

2022

Contains fulltext : 249581.pdf (Publisher’s version ) (Closed access) PURPOSE: To investigate the impact of physical activity (PA) on the incidence or progression of age-related macular degeneration (AMD) in the general population. DESIGN: Meta-analysis of longitudinal cohort studies. METHODS: We included 14,630 adults with no or early AMD at baseline from 7 population-based studies and examined associations of PA with AMD incidence and progression using multistate models (MSM) per study and subsequent random effects meta-analysis. Age effects were assessed using meta-regression. The main outcome measure was the hazard ratio (HR) for incident early or progression to late AMD. RESULTS: At ba…

Adultmedicine.medical_specialtygenetic structuresPopulationPhysical activitySensory disorders Donders Center for Medical Neuroscience [Radboudumc 12]Cohort Studies03 medical and health sciencesMacular Degeneration0302 clinical medicineSDG 3 - Good Health and Well-beingRisk FactorsInternal medicineAge relatedmedicineHumansLongitudinal StudiesRisk factoreducationExerciseAgededucation.field_of_studybusiness.industryIncidence (epidemiology)IncidenceHazard ratioMacular degenerationMiddle Agedmedicine.diseaseeye diseases3. Good healthOphthalmology030221 ophthalmology & optometryDisease Progression[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologiesense organsbusiness030217 neurology & neurosurgeryCohort studyFollow-Up Studies
researchProduct

Splenic lymphangiomatosis showing rapid growth during lactation: a case report.

2010

Splenic lymphangiomatosis is a very rare condition that, from 1990 to date, has been described only nine times. In the present report, we describe the first case of splenic lymphangiomatosis with rapid growth during lactation in a 35-year-old woman. We also underline the difficultly in making an accurate preoperative diagnosis, despite more modern imaging techniques. Total splenectomy was considered to be the treatment needed, both to make a definitive diagnosis and to exclude the presence of malignancy.

Adultmedicine.medical_specialtymedicine.medical_treatmentBiopsySplenectomySplenic NeoplasmCase ReportMalignancyPredictive Value of TestsLactationLymphangiomaBiopsyLymphangiomatosiMedicineHumansLactationLymphangiomatosismedicine.diagnostic_testLymphangiomabusiness.industrySplenic NeoplasmsGastroenterologyGeneral Medicinemedicine.diseaseSurgerymedicine.anatomical_structureTreatment OutcomePredictive value of testsDisease ProgressionSplenectomyFemalebusinessTomography X-Ray ComputedSpleen
researchProduct

Test MetAphAs. Metalinguagem na Avaliação da Afasia

2020

Test MetAphAs. Metalinguagem na Avaliação da Afasia (Rosell-Clari & Hernández-Sacristán, 2020) es una versión adaptada al portugués y abreviada de Rosell Clari & Hernández Sacristán, 2014). Esta prueba fue desarrollada inicialmente para evaluar las habilidades metalingüísticas naturales en personas con afasia (Hernández-Sacristán, Rosell-Clari, Serra-Alegre y Quiles-Climent, 2012). Las habilidades metalingüísticas naturales se refieren al uso del lenguaje que revela reflexividad (Hockett, 1960); es decir, la distancia perceptiva del hablante con respecto a su propio comportamiento verbal (Werner & Kaplan, 1978). Esta autoconciencia del lenguaje nos permite monitorear nuestros propios compor…

AfasiaEvaluación MetalenguajeAfasia Progresiva PrimariaMatalenguaje
researchProduct

Docetaxel plus prednisone in patients with metastatic hormone-refractory prostate cancer: An Italian clinical experience

2011

Aims and Background: We investigated the efficacy of docetaxel plus prednisone in Italian patients with metastatic hormone- refractory prostate cancer (mHRPC). Methods: Twenty four patients with mHRPC received docetaxel 75 mg/m2 every 3 weeks plus prednisone 5 mg twice daily for up to six cycles. The primary endpoint was efficacy measured by a reduction in serum prostate specific antigen (PSA) levels and measurable disease. Evaluation of toxicity, quality of life and reduction of pain were secondary endpoints. Results: PSA response was seen in 18 patients (75%). We observed a partial response in 2 patients (8.3%), stable disease in 10 patients (41.7%), and disease progression in 12 patients…

Aged 80 and overMaleTime FactorsAntineoplastic Agents HormonalSettore MED/06 - Oncologia MedicaProstatic NeoplasmsDocetaxelAdenocarcinomaMiddle AgedProstate-Specific AntigenTreatment OutcomeItalyDrug Resistance NeoplasmAntineoplastic Combined Chemotherapy ProtocolsDisease ProgressionHumansPrednisoneTaxoidsAdenocarcinoma Antineoplastic combined chemiotherapy protocols Docetaxel Drug-resistace Neoplasm Prednisone Prostatic neoplasm TaxoidsAgedNeoplasm Staging
researchProduct

Serum BPIFB4 levels classify health status in long-living individuals

2015

Background People that reach extreme ages (Long-Living Individuals, LLIs) are object of intense investigation for increase/decrease of genetic variant frequencies, genetic methylation levels, protein abundance in serum and tissues. The aim of these studies is the discovery of the mechanisms behind LLIs extreme longevity and the identification of markers of well-being. We have recently associated a BPIFB4 haplotype (LAV) with exceptional longevity under a homozygous genetic model, and identified that CD34+ of LLIs subjects express higher BPIFB4 transcript as compared to CD34+ of control population. It would be of interest to correlate serum BPIFB4 protein levels with exceptional longevity an…

AgingbiologyResearchmedia_common.quotation_subjectBPIFB4Disease progressionHaplotypeImmunologyBPIFB4; CD34; Methylation; Vascular ageingLongevityMethylationClinical nutritionVascular ageingMethylationAgeingImmunologyExtreme longevity trackingGenetic modelbiology.proteinCD34Antibodymedia_commonImmunity & Ageing
researchProduct

Chronic gout in the elderly

2013

Gout is the most common cause of inflammatory arthritis in men over 40 years old; it is a debilitating disease and, if untreated, can result in a chronic progressive disease, including tophaceous gout. In the elderly it represents a special issue, with notable clinical and therapeutic differences from the classical form with a systemic involvement. The burden of the disease increases particularly in the very old people, in whom arthritis, impaired gait and eyesight problems may enhance the related disability. Chronic gout moreover could aggravate heart and kidney disease and increase overall mortality and organ-related damage. Early diagnosis and appropriate treatment are important goals fo…

Agingmedicine.medical_specialtyGoutInflammatory arthritisArthritisDiseaseHyperuricemiaGout SuppressantsChronic gout Hyperuricemia Tophi Older ageRisk FactorsEpidemiologymedicineHumansHyperuricemiaIntensive care medicineLife StyleAgedbusiness.industrymedicine.diseaseGoutChronic DiseasePhysical therapyGeriatrics and GerontologybusinessProgressive diseaseKidney disease
researchProduct

Cancer relapse under chemotherapy: why TLR2/4 receptor agonists can help.

2007

Liver or lung metastases usually relapse under chemotherapy. Such life-threatening condition urgently needs new, systemic anticancer compounds, with original and efficient mechanisms of action. In B16 melanoma mice treated with cyclophosphamide, D'Agostini et al. [D'Agostini, C., Pica, F., Febbraro, G., Grelli, S., Chiavaroli, C., Garaci, E., 2005. Antitumour effect of OM-174 and Cyclophosphamide on murine B16 melanoma in different experimental conditions. Int. Immunopharmacol. 5, 1205-1212.] recently found that OM-174, a chemically defined Toll-like receptor(TLR)2/4 agonist, reduces tumor progression and prolongs survival. Here we review 149 articles concerning molecular mechanisms of TLR2…

AgonistLipopolysaccharidesCyclophosphamidemedicine.drug_classmedicine.medical_treatmentNitric Oxide Synthase Type IIAntineoplastic AgentsApoptosisNitric oxidechemistry.chemical_compoundRecurrenceNeoplasmsMedicineAnimalsHumansPharmacologyChemotherapybusiness.industryTumor Necrosis Factor-alphaCancerDendritic Cellsmedicine.diseaseNeoadjuvant TherapyToll-Like Receptor 2Interleukin-10Toll-Like Receptor 4TLR2Lipid ATreatment OutcomechemistryTumor progressionChemotherapy AdjuvantDrug Resistance NeoplasmEnzyme InductionImmunologyCancer researchBCG VaccineTumor necrosis factor alphaImmunotherapybusinessmedicine.drugSignal TransductionT-Lymphocytes CytotoxicEuropean journal of pharmacology
researchProduct

Mujer, poder político y democracia paritaria. “Mujer y representación política institucional en la Comunidad Valenciana. 1977-1995. 2 parte.

2014

Mujer, poder político y democracia paritaria. “Mujer y representación política institucional en la Comunidad Valenciana. 1977-1995. 2 parte. En esta segunda parte se recogen las mujeres que han formado parte de la Administración Local (alcaldesas, diputadas provinciales y FVMP), en los sindicatos, asi como en otras instituciones: Consell Valencià de Cultura, Consejo de Radiotelevisión Valenciana, Sindicatura de Agravios, Academia Valenciana de la Lengua, universidades, direcciones de partidos políticos, y otras organizaciones de la Comunidad Valenciana. “Mujer y representación política institucional en la Comunidad Valenciana. 1977-1995. Diputadas, ministras y cargos institucionales” es la …

Alcaldesas de la Comunidad Valenciana. Clementina Rodenas Villena. Rita Barberá Nolla. Josefa Mateu. Rosa Mazón. Carmen Gimeno. María Cabanes. Vicenta Bosch Palanca. Josefa Mateu. Violeta Rivera. Rosa Mengual. Empar Navarro i Prosper. Celeste García Estarlich. Mª. Dolores Botella Arbona. Carmen Martínez Ramírez. Gloria Isabel Calero Albal. Francisca R. Viciano Guillem. Teresa Parra Almiñana. Vicenta Tortosa Urrea. Rosa Maria Verdú Ramos. Mª. Milagrosa Martínez Navarro. Ana Noguera. María Ángeles Crespo Martínez. María Emma Iranzo Martín. Amparo Belmonte Burgos. María Ángeles Crespo Martínez. Lina Insa Rico. Teresa Ballester Artigues. Elena María Bastidas Bono. Mª. Elena Albentosa Ruso. María Rosa Verdú Alonso. María José Torres Amorós. María José García Herrero. Antonia Martínez Soler. Mª del Carmen Martínez Clemor. Enriqueta Seller Roca de Togores. Juliana González Maillo. Mercedes Alonso García. Mª de los Frutos Barceló La Torre. Luisa Pastor Lillo. Mª Antonieta Carratalá Aracil. María del Carmen Jiménez Egea. María Milagros Diego Martínez. Ana María Kringe Sánchez. Josefa Martín Bru. Luisa Pastor Lillo. María Gloria Pérez Martínez. María Teresa Sempere Juan. María Teresa Carbonell Bernabeu. María Loreto Martínez Ramos. Alicia Vázquez Fernández. Carmen García-Fuster y González-Alegre. Encarna Lerma Blasco. Francisca Gimeno Mocholi.Concha Martínez Romero. María A. Crespo Martínez. Gloria Arnandis Boix. Rosa Isabel Ribes Abel. Margarita Pin Arboledas. Nuria Espí de Navas. Purificación Martí Fenollosa. Asunción Quinzá Alegre. María Consuelo Orias Gonzalvo. Ascensión Figueres Górriz. María Remedios Vila Castelló. Mª Luisa Oliver Mallasén. Herminia Palomar Pérez. María Teresa Sidro. Carmina Martinavarro Moya. Consuelo Sanz Molés. Concepción Saenz Laín. Gobernadora civil de Castellón. Carmen Moya García delegada del Gobierno en la Comunidad Valenciana. Carmen Mas Rubio delegada del Gobierno en la Comunidad Valenciana. Pilar Brabo. Dulce Contreras Isabel Segura Maria Antonia García Benau. Cristina Santamaría Siurana. Isabel Morant. Adela Cortina. Neus Campillo. Trinidad Simó. Remedios Sánchez entre otras. Irene Abad Miró. María Francisca Abad García. Mari Luz Terradas. Amparo Caballer Cabo.Foro de Opinión. María Dolores Vilanova Alonso. Amparo Llop. María José Reyes. Mariló Pla. Cristina Piris. Victoria Prades. Mari Luz Marco. Julia Carles. Elisa Cabanes. Magarita Sanz Alonso. Ofelia Vila Hernández. Carme Morenilla i Talens. Rosa Mª Magdalena Rodríguez Pérez. Rosa Serrano Llácer. Síndic de Greuges de la Comunidad Valenciana. Julia Sevilla Merino. Emilia Caballero Álvarez. Ascensión Figueres Górriz. Carmen Barceló Torres. Verónica Cantó Doménech. Maria Soledad González Felip. Amàlia Alba Tarazona. Dones Progressistes. Susana Camarero Benitez. Macarena Montesinos. Marcela Miró Pérez. Pepa Chesa. Mª Josep Amigó. Teresa Blat. Lobby Europeo de Mujeres. Rosa Solbes. Inmaculada Serra Yoldi.:CIENCIA POLÍTICA [UNESCO]UNESCO::CIENCIA POLÍTICA
researchProduct

Progressive Era Racism and its (Jewish) Discontents

2018

This work analyzes the contribution to the debates on labor and immigration of a group of Jewish academicians and reformers who, during the second half of the Progressive Era, explicitly took a stance against the racialist and eugenic rhetoric of the period. This group includes first-rank economists like Edwin R. A. Seligman, Jacob H. Hollander, and Emanuel A. Goldenweiser; influential field specialists such as Isaac A. Hourwich and Isaac M. Rubinow; and relatively less known figures like Max J. Kohler and Samuel K. Joseph. By focusing on the voices of these dissenters, the work enriches the emerging picture of Progressive Era eugenic and racial thought

American Progressive Era Edwin R. A. Seligman Immigration Race Anti-SemitismSettore SECS-P/04 - Storia Del Pensiero Economico
researchProduct

Wesley Clair Mitchell and the “Illiberal Reformers”: A Documentary Note

2021

In this note we inquire whether Mitchell as a reformer ever expressed concern over the biological quality of individuals and whether he did somehow share the Progressive Era faith in eugenics as an instrument for improving American society’s health, welfare, and morals. This is an aspect of Mitchell’s thought that has received scant attention in the literature and that projects him into the current debate on progressivism.

American Progressive EraRaceEugenicSettore SECS-P/04 - Storia Del Pensiero EconomicoAmerican Progressive Era; Mitchell Wesley Clair; Immigration; Race; EugenicImmigrationWesley ClairProgressivismMitchell Wesley C.Mitchell
researchProduct